RecruitingNCT04296071

Neutrophil Phenotypic Profiling and Acute Lung Injury in Patients After Cardiopulmonary Bypass (CPB)


Sponsor

Sophia Koutsogiannaki

Enrollment

56 participants

Start Date

Oct 14, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Acute lung injury (ALI) following cardiopulmonary bypass (CPB) is a serious complication, often prolonging the length of stay in ICU and potentially dealing to mortality. The objective of this study is to assess the mechanism of CPB-mediated acute lung injury in pediatric patients.


Eligibility

Max Age: 12 Months

Inclusion Criteria3

  • Are < 12months of age
  • Scheduled for cardiac surgical needing CPB
  • Preoperative SpO2 > 90%

Exclusion Criteria3

  • Lack of parental (or legal guardian's) consent
  • Preoperative SpO2 < 90%
  • Preoperative oxygen therapy

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERResearch study

Blood and tracheal aspirates will be collected


Locations(1)

Boston Children's Hospital

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04296071


Related Trials